Literature DB >> 20890882

Destruction of bacterial biofilms by polymorphonuclear neutrophils: relative contribution of phagocytosis, DNA release, and degranulation.

Eva Meyle1, Petra Stroh, Frank Günther, Torsten Hoppy-Tichy, Christof Wagner, G Maria Hänsch.   

Abstract

Bacteria organized in biofilms are a common cause of relapsing or persistent infections, and the ultimate cause of implant-associated osteomyelitis. In these patients, biofilms of staphylococci are prevalent. Bacteria organized as biofilms are relatively resistant towards antibiotics and biocides, and it is also assumed that they may escape host defense mechanisms. In this context, we have studied how polymorphonuclear neutrophils (PMN), the "first line of defense" against bacterial infection, interact with biofilms generated in vitro. We found that PMN recognize biofilms and activate defense-associated reactions, including phagocytosis, degranulation of lactoferrin and elastase, and DNA release as well. Destruction of biofilms ensues, showing that biofilms are not inherently protected against the attack by phagocytic cells.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20890882     DOI: 10.1177/039139881003300906

Source DB:  PubMed          Journal:  Int J Artif Organs        ISSN: 0391-3988            Impact factor:   1.595


  26 in total

1.  Residence in biofilms allows Burkholderia cepacia complex (Bcc) bacteria to evade the antimicrobial activities of neutrophil-like dHL60 cells.

Authors:  Mark P Murphy; Emma Caraher
Journal:  Pathog Dis       Date:  2015-09-13       Impact factor: 3.166

2.  Changes in the extracellular matrix surrounding human chronic wounds revealed by 2-photon imaging.

Authors:  Jessica E S Sutcliffe; Christopher Thrasivoulou; Thomas E Serena; Leigh Madden; Toby Richards; Anthony R J Phillips; David L Becker
Journal:  Int Wound J       Date:  2017-07-20       Impact factor: 3.315

3.  Determinants for persistence of Pseudomonas aeruginosa in hospitals: interplay between resistance, virulence and biofilm formation.

Authors:  S J Kaiser; N T Mutters; A DeRosa; C Ewers; U Frank; F Günther
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-10-12       Impact factor: 3.267

4.  Inhibition and Dispersal of Pseudomonas aeruginosa Biofilms by Combination Treatment with Escapin Intermediate Products and Hydrogen Peroxide.

Authors:  Ariel J Santiago; Marwa N A Ahmed; Shu-Lin Wang; Krishna Damera; Binghe Wang; Phang C Tai; Eric S Gilbert; Charles D Derby
Journal:  Antimicrob Agents Chemother       Date:  2016-08-22       Impact factor: 5.191

Review 5.  Pathogenic microbes and community service through manipulation of innate immunity.

Authors:  George Hajishengallis; Jennifer L Krauss; Shuang Liang; Megan L McIntosh; John D Lambris
Journal:  Adv Exp Med Biol       Date:  2012       Impact factor: 2.622

Review 6.  Significance of biofilm for the prosthetic surgeon.

Authors:  R Charles Welliver; Brittney L Hanerhoff; Gerard D Henry; Tobias S Köhler
Journal:  Curr Urol Rep       Date:  2014-06       Impact factor: 3.092

7.  Sublethal concentrations of carbapenems alter cell morphology and genomic expression of Klebsiella pneumoniae biofilms.

Authors:  Tricia A Van Laar; Tsute Chen; Tao You; Kai P Leung
Journal:  Antimicrob Agents Chemother       Date:  2015-01-12       Impact factor: 5.191

8.  Activation of phagocytic cells by Staphylococcus epidermidis biofilms: effects of extracellular matrix proteins and the bacterial stress protein GroEL on netosis and MRP-14 release.

Authors:  Ulrike Dapunt; Matthias M Gaida; Eva Meyle; Birgit Prior; Gertrud M Hänsch
Journal:  Pathog Dis       Date:  2016-04-23       Impact factor: 3.166

Review 9.  Breaking bad: manipulation of the host response by Porphyromonas gingivalis.

Authors:  George Hajishengallis; Richard J Lamont
Journal:  Eur J Immunol       Date:  2014-02       Impact factor: 5.532

10.  Effect of salivary agglutination on oral streptococcal clearance by human polymorphonuclear neutrophil granulocytes.

Authors:  A Itzek; Z Chen; J Merritt; J Kreth
Journal:  Mol Oral Microbiol       Date:  2016-07-10       Impact factor: 3.563

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.